Iotron Medical Inc.

Columbia City,  IN 
United States
  • Booth: SB10

Iotron Medical has been working with the Argonne National Laboratory since 2011 on the scale-up of copper-67 radioisotope production using high-energy electron beam.  Copper-67 is a beta emitter with highly desirable properties for theranostic targeted radioisotope therapy (small molecule or antibodies).  It can also be paired with copper-64 for detailed PET imaging.

Copper-67 is being produced today at 3 sites in North America in quantities sufficient to support on-going pre-clinical and clinical development.  Iotron will commission a commercial-scale production facility for copper-67 to meet growing demand as therapies progress through clinical trials.  The Argonne technology is the only proven method for production of high specific activity copper-67 in the multi-Curie quantities needed to support premarket approved radiopharmaceuticals. 

Iotron Medical is part of the Iotron group, an organization pioneering the use of electron beam technology in a wide variety of applications since 1991.  Electron beam is used at Iotron’s sites in Vancouver, Canada and Columbia City, Indiana, USA to sterilize medical devices, cross-link polymers used in orthopedics, and sanitize agricultural products.  These processes are all carried out to current Good Manufacturing Practice standards.

For more information please visit or


For Technical Support with this webpage, please contact support.